TreeWAS – Variant ID: rs4549702

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
T36-T50 Poisoning by drugs, medicaments and biological substances	0.980	0.020	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.974	0.026	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.969	0.031	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.966	0.034	0.000
T43.2 Other and unspecified antidepressants	0.945	0.055	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.935	0.065	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.932	0.068	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.913	0.087	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.900	0.100	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.895	0.105	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.888	0.112	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.870	0.130	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.809	0.191	0.000
T42.4 Benzodiazepines	0.809	0.191	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.791	0.209	0.000
T42.3 Barbiturates	0.789	0.211	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.788	0.212	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.787	0.213	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.779	0.221	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.759	0.241	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.756	0.244	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.748	0.252	0.000
T38.0 Glucocorticoids and synthetic analogues	0.743	0.257	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.735	0.265	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.734	0.266	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.728	0.272	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.722	0.278	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.719	0.281	0.000
T42.1 Iminostilbenes	0.716	0.284	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.713	0.287	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.709	0.291	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.704	0.296	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.703	0.297	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.698	0.302	0.000
T46.7 Peripheral vasodilators	0.698	0.302	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.698	0.302	0.000
T38.1 Thyroid hormones and substitutes	0.696	0.304	0.000
T43.9 Psychotropic drug, unspecified	0.695	0.305	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.695	0.305	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.692	0.307	0.000
T42.2 Succinimides and oxazolidinediones	0.692	0.307	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.691	0.309	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.674	0.326	0.000
T40.6 Other and unspecified narcotics	0.673	0.327	0.000
T42.0 Hydantoin derivatives	0.672	0.328	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.671	0.329	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.670	0.330	0.000
T36 Poisoning by systemic antibiotics	0.669	0.331	0.000
T50.8 Diagnostic agents	0.664	0.336	0.000
T43.6 Psychostimulants with abuse potential	0.659	0.341	0.000
T38.9 Other and unspecified hormone antagonists	0.642	0.358	0.000
T38.7 Androgens and anabolic congeners	0.642	0.358	0.000
T38.5 Other oestrogens and progestogens	0.642	0.358	0.000
T38.4 Oral contraceptives	0.642	0.358	0.000
T38.2 Antithyroid drugs	0.642	0.358	0.000
T50.4 Drugs affecting uric acid metabolism	0.640	0.360	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.639	0.361	0.000
T50.7 Analeptics and opioid receptor antagonists	0.636	0.364	0.000
T50.5 Appetite depressants	0.636	0.364	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.636	0.364	0.000
T50.1 Loop [high-ceiling] diuretics	0.636	0.364	0.000
T50.0 Mineralocorticoids and their antagonists	0.636	0.364	0.000
T45.2 Vitamins, not elsewhere classified	0.629	0.371	0.000
T47.0 Histamine H(2)-receptor antagonists	0.627	0.373	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.624	0.376	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.624	0.376	0.000
T47.7 Emetics	0.624	0.376	0.000
T47.6 Antidiarrhoeal drugs	0.624	0.376	0.000
T47.5 Digestants	0.624	0.376	0.000
T47.4 Other laxatives	0.624	0.376	0.000
T47.3 Saline and osmotic laxatives	0.624	0.376	0.000
T47.2 Stimulant laxatives	0.624	0.376	0.000
T40.1 Heroin	0.604	0.396	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.600	0.400	0.000
T40.3 Methadone	0.595	0.404	0.000
T40.5 Cocaine	0.595	0.405	0.000
T46.1 Calcium-channel blockers	0.578	0.421	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.570	0.430	0.000
T40.4 Other synthetic narcotics	0.567	0.433	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.565	0.435	0.000
T40.8 Lysergide [LSD]	0.565	0.435	0.000
T40.7 Cannabis (derivatives)	0.565	0.435	0.000
T40.0 Opium	0.565	0.435	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.562	0.438	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.553	0.447	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.537	0.463	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.530	0.470	0.000
T36.8 Other systemic antibiotics	0.524	0.476	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.522	0.478	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.522	0.478	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.522	0.478	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.522	0.478	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.522	0.478	0.000
T44.0 Anticholinesterase agents	0.522	0.478	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.521	0.479	0.000
T49.9 Topical agent, unspecified	0.518	0.482	0.000
T49.8 Other topical agents	0.518	0.482	0.000
T49.7 Dental drugs, topically applied	0.518	0.482	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.518	0.482	0.000
T49.5 Ophthalmological drugs and preparations	0.518	0.482	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.518	0.482	0.000
T49.3 Emollients, demulcents and protectants	0.518	0.482	0.000
T49.2 Local astringents and local detergents	0.518	0.482	0.000
T49.1 Antipruritics	0.518	0.482	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.511	0.489	0.000
T37.5 Antiviral drugs	0.511	0.489	0.000
T37.4 Anthelminthics	0.511	0.489	0.000
T37.3 Other antiprotozoal drugs	0.511	0.489	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.511	0.489	0.000
T37.1 Antimycobacterial drugs	0.511	0.489	0.000
T37.0 Sulphonamides	0.511	0.489	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.508	0.492	0.000
T45.8 Other primarily systemic and haematological agents	0.508	0.492	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.508	0.492	0.000
T45.6 Fibrinolysis-affecting drugs	0.508	0.492	0.000
T45.4 Iron and its compounds	0.508	0.492	0.000
T45.3 Enzymes, not elsewhere classified	0.508	0.492	0.000
T45.5 Anticoagulants	0.508	0.492	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.507	0.493	0.000
T41.5 Therapeutic gases	0.504	0.496	0.000
T41.4 Anaesthetic, unspecified	0.504	0.496	0.000
T41.3 Local anaesthetics	0.504	0.496	0.000
T41.2 Other and unspecified general anaesthetics	0.504	0.496	0.000
T41.1 Intravenous anaesthetics	0.504	0.496	0.000
T41.0 Inhaled anaesthetics	0.504	0.496	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.502	0.498	0.000
T36.3 Macrolides	0.497	0.503	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.495	0.505	0.000
T48.4 Expectorants	0.495	0.505	0.000
T48.3 Antitussives	0.495	0.505	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.495	0.505	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.495	0.505	0.000
T48.0 Oxytocic drugs	0.495	0.505	0.000
T36.9 Systemic antibiotic, unspecified	0.479	0.520	0.000
T36.7 Antifungal antibiotics, systemically used	0.479	0.520	0.000
T36.6 Rifamycins	0.479	0.520	0.000
T36.5 Aminoglycosides	0.479	0.520	0.000
T36.4 Tetracyclines	0.479	0.520	0.000
T36.2 Chloramphenicol group	0.479	0.520	0.000
T48.5 Anti-common-cold drugs	0.470	0.530	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.456	0.544	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.423	0.576	0.000
T40.2 Other opioids	0.348	0.652	0.000
T45.0 Antiallergic and antiemetic drugs	0.321	0.678	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.312	0.688	0.000
T36.0 Penicillins	0.305	0.694	0.001
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.267	0.733	0.000
T39.4 Antirheumatics, not elsewhere classified	0.224	0.776	0.000
T39.2 Pyrazolone derivatives	0.224	0.776	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.215	0.785	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.195	0.805	0.000
T39.0 Salicylates	0.111	0.889	0.000
T39.1 4-Aminophenol derivatives	0.034	0.966	0.000
M24.13 Other articular cartilage disorders (Forearm)	0.000	0.977	0.023
M24.1 Other articular cartilage disorders	0.000	0.977	0.023
M24.17 Other articular cartilage disorders (Ankle and foot)	0.000	0.979	0.021
M24.15 Other articular cartilage disorders (Pelvic region and thigh)	0.000	0.980	0.020
M24.16 Other articular cartilage disorders (Lower leg)	0.000	0.981	0.019
M24.11 Other articular cartilage disorders (Shoulder region)	0.000	0.981	0.019
M24.19 Other articular cartilage disorders (Site unspecified)	0.000	0.983	0.016
M24.18 Other articular cartilage disorders (Other)	0.000	0.983	0.016
M24.14 Other articular cartilage disorders (Hand)	0.000	0.983	0.016
M24.12 Other articular cartilage disorders (Upper arm)	0.000	0.983	0.016
M24.10 Other articular cartilage disorders (Multiple sites)	0.000	0.983	0.016
L91.8 Other hypertrophic disorders of skin	0.016	0.984	0.000
M24.07 Loose body in joint (Ankle and foot)	0.000	0.990	0.010
Z90.5 Acquired absence of kidney	0.009	0.991	0.000
M24 Other specific joint derangements	0.000	0.991	0.009
M24.0 Loose body in joint	0.000	0.991	0.009
N87.1 Moderate cervical dysplasia	0.000	0.991	0.009
M24.4 Recurrent dislocation and subluxation of joint	0.000	0.993	0.007
H44.2 Degenerative myopia	0.000	0.993	0.007
M24.03 Loose body in joint (Forearm)	0.000	0.993	0.007
N87.0 Mild cervical dysplasia	0.000	0.993	0.007
M24.9 Joint derangement, unspecified	0.000	0.993	0.007
M24.09 Loose body in joint (Site unspecified)	0.000	0.993	0.006
M24.08 Loose body in joint (Other)	0.000	0.993	0.006
M24.06 Loose body in joint-Lower leg	0.000	0.993	0.006
M24.05 Loose body in joint (Pelvic region and thigh)	0.000	0.993	0.006
M24.00 Loose body in joint (Multiple sites)	0.000	0.993	0.006
L91 Hypertrophic disorders of skin	0.007	0.993	0.000
N87 Dysplasia of cervix uteri	0.000	0.993	0.007
M24.45 Recurrent dislocation and subluxation of joint (Pelvic region and thigh)	0.000	0.993	0.007
M24.7 Protrusio acetabuli	0.000	0.993	0.007
M86.97 Osteomyelitis, unspecified (Ankle and foot)	0.000	0.994	0.006
M24.5 Contracture of joint	0.000	0.994	0.006
M24.3 Pathological dislocation and subluxation of joint, not elsewhere classified	0.000	0.994	0.006
M24.44 Recurrent dislocation and subluxation of joint (Hand)	0.000	0.994	0.006
M24.04 Loose body in joint (Hand)	0.000	0.994	0.006
G30.9 Alzheimer's disease, unspecified	0.006	0.994	0.000
L91.0 Keloid scar	0.006	0.994	0.000
M24.47 Recurrent dislocation and subluxation of joint (Ankle and foot)	0.000	0.994	0.006
M24.01 Loose body in joint (Shoulder region)	0.000	0.994	0.006
M24.49 Recurrent dislocation and subluxation of joint (Site unspecified)	0.000	0.994	0.005
M24.48 Recurrent dislocation and subluxation of joint (Other)	0.000	0.994	0.005
M24.46 Recurrent dislocation and subluxation of joint (Lower leg)	0.000	0.994	0.005
M24.43 Recurrent dislocation and subluxation of joint (Forearm)	0.000	0.994	0.005
M24.42 Recurrent dislocation and subluxation of joint (Upper arm)	0.000	0.994	0.005
M24.40 Recurrent dislocation and subluxation of joint (Multiple sites)	0.000	0.994	0.005
M24.6 Ankylosis of joint	0.000	0.994	0.005
M24.2 Disorder of ligament	0.000	0.994	0.005
M24.27 Disorder of ligament (Ankle and foot)	0.000	0.995	0.005
M24.57 Contracture of joint (Ankle and foot)	0.000	0.995	0.005
M24.02 Loose body in joint (Upper arm)	0.000	0.995	0.005
C71.2 Temporal lobe	0.005	0.995	0.000
C71 Malignant neoplasm of brain	0.005	0.995	0.000
M24.99 Joint derangement, unspecified (Site unspecified)	0.000	0.995	0.005
M24.98 Joint derangement, unspecified (Other)	0.000	0.995	0.005
M24.97 Joint derangement, unspecified (Ankle and foot)	0.000	0.995	0.005
M24.96 Joint derangement, unspecified (Lower leg)	0.000	0.995	0.005
M24.95 Joint derangement, unspecified (Pelvic region and thigh)	0.000	0.995	0.005
M24.94 Joint derangement, unspecified (Hand)	0.000	0.995	0.005
M24.93 Joint derangement, unspecified (Forearm)	0.000	0.995	0.005
M24.92 Joint derangement, unspecified (Upper arm)	0.000	0.995	0.005
M24.91 Joint derangement, unspecified (Shoulder region)	0.000	0.995	0.005
M24.90 Joint derangement, unspecified (Multiple sites)	0.000	0.995	0.005
M24.79 Protrusio acetabuli-Site unspec	0.000	0.995	0.005
M24.78 Protrusio acetabuli-Other	0.000	0.995	0.005
M24.77 Protrusio acetabuli-Ankle/foot	0.000	0.995	0.005
M24.76 Protrusio acetabuli-Lower leg	0.000	0.995	0.005
M24.74 Protrusio acetabuli-Hand	0.000	0.995	0.005
M24.73 Protrusio acetabuli-Forearm	0.000	0.995	0.005
M24.72 Protrusio acetabuli-Upper arm	0.000	0.995	0.005
M24.71 Protrusio acetabuli-Shldr region	0.000	0.995	0.005
M24.70 Protrusio acetabuli-Mult sites	0.000	0.995	0.005
M24.75 Protrusio acetabuli-Pelvic/thigh	0.000	0.995	0.005
N87.9 Dysplasia of cervix uteri, unspecified	0.000	0.995	0.005
C71.1 Frontal lobe	0.005	0.995	0.000
N87.2 Severe cervical dysplasia, not elsewhere classified	0.000	0.995	0.005
R93.1 Abnormal findings on diagnostic imaging of heart and coronary circulation	0.005	0.995	0.000
M24.54 Contracture of joint (Hand)	0.000	0.995	0.005
M24.39 Pathological dislocation and subluxation of joint, not elsewhere classified (Site unspecified)	0.000	0.995	0.005
M24.38 Pathological dislocation and subluxation of joint, not elsewhere classified (Other)	0.000	0.995	0.005
M24.36 Pathological dislocation and subluxation of joint, not elsewhere classified (Lower leg)	0.000	0.995	0.005
M24.35 Pathological dislocation and subluxation of joint, not elsewhere classified (Pelvic region and thigh)	0.000	0.995	0.005
M24.34 Pathological dislocation and subluxation of joint, not elsewhere classified (Hand)	0.000	0.995	0.005
M24.33 Pathological dislocation and subluxation of joint, not elsewhere classified (Forearm)	0.000	0.995	0.005
M24.32 Pathological dislocation and subluxation of joint, not elsewhere classified (Upper arm)	0.000	0.995	0.005
M24.31 Pathological dislocation and subluxation of joint, not elsewhere classified (Shoulder region)	0.000	0.995	0.005
M24.30 Pathological dislocation and subluxation of joint, not elsewhere classified (Multiple sites)	0.000	0.995	0.005
M24.59 Contracture of joint (Site unspecified)	0.000	0.995	0.005
M24.58 Contracture of joint (Other)	0.000	0.995	0.005
M24.53 Contracture of joint (Forearm)	0.000	0.995	0.005
M24.50 Contracture of joint (Multiple sites)	0.000	0.995	0.005
C71.4 Occipital lobe	0.005	0.995	0.000
H10.9 Conjunctivitis, unspecified	0.005	0.995	0.000
M24.55 Contracture of joint (Pelvic region and thigh)	0.000	0.995	0.004
M24.51 Contracture of joint (Shoulder region)	0.000	0.995	0.004
C71.7 Brain stem	0.004	0.995	0.000
M24.52 Contracture of joint (Upper arm)	0.000	0.995	0.004
O86.0 Infection of obstetric surgical wound	0.004	0.996	0.000
N48.0 Leukoplakia of penis	0.004	0.996	0.000
C71.5 Cerebral ventricle	0.004	0.996	0.000
C71.9 Brain, unspecified	0.004	0.996	0.000
D17.6 Benign lipomatous neoplasm of spermatic cord	0.004	0.996	0.000
N41.0 Acute prostatitis	0.000	0.996	0.004
M24.28 Disorder of ligament (Other)	0.000	0.996	0.004
M24.37 Pathological dislocation and subluxation of joint, not elsewhere classified (Ankle and foot)	0.000	0.996	0.004
M24.67 Ankylosis of joint (Ankle and foot)	0.000	0.996	0.004
L40.9 Psoriasis, unspecified	0.004	0.996	0.000
M24.29 Disorder of ligament (Site unspecified)	0.000	0.996	0.004
M24.25 Disorder of ligament (Pelvic region and thigh)	0.000	0.996	0.004
M24.22 Disorder of ligament (Upper arm)	0.000	0.996	0.004
M24.20 Disorder of ligament (Multiple sites)	0.000	0.996	0.004
M24.69 Ankylosis of joint (Site unspecified)	0.000	0.996	0.004
M24.68 Ankylosis of joint (Other)	0.000	0.996	0.004
M24.63 Ankylosis of joint (Forearm)	0.000	0.996	0.004
M24.62 Ankylosis of joint (Upper arm)	0.000	0.996	0.004
M24.61 Ankylosis of joint (Shoulder region)	0.000	0.996	0.004
M24.60 Ankylosis of joint (Multiple sites)	0.000	0.996	0.004
M86.9 Osteomyelitis, unspecified	0.000	0.996	0.004
M24.65 Ankylosis of joint (Pelvic region and thigh)	0.000	0.996	0.004
T51.0 Ethanol	0.004	0.996	0.000
M24.66 Ankylosis of joint (Lower leg)	0.000	0.996	0.004
C71.6 Cerebellum	0.004	0.996	0.000
M24.56 Contracture of joint (Lower leg)	0.000	0.996	0.004
M24.8 Other specific joint derangements, not elsewhere classified	0.000	0.996	0.004
M86.99 Osteomyelitis, unspecified (Site unspecified)	0.000	0.996	0.004
C71.8 Overlapping lesion of brain	0.004	0.996	0.000
B02.3 Zoster ocular disease	0.000	0.996	0.004
M24.24 Disorder of ligament (Hand)	0.000	0.996	0.004
M24.23 Disorder of ligament (Forearm)	0.000	0.996	0.004
N48.1 Balanoposthitis	0.004	0.996	0.000
M86.98 Osteomyelitis, unspecified (Other)	0.000	0.996	0.004
Y45.2 Propionic acid derivatives	0.004	0.996	0.000
M24.64 Ankylosis of joint (Hand)	0.000	0.996	0.003
L91.9 Hypertrophic disorder of skin, unspecified	0.003	0.997	0.001
M24.21 Disorder of ligament (Shoulder region)	0.000	0.997	0.003
I72.4 Aneurysm of artery of lower extremity	0.003	0.997	0.000
M25.51 Pain in joint (Shoulder region)	0.000	0.997	0.003
L98.0 Pyogenic granuloma	0.003	0.997	0.000
M24.84 Other specific joint derangements, not elsewhere classified (Hand)	0.000	0.997	0.003
C71.3 Parietal lobe	0.003	0.997	0.000
O86 Other puerperal infections	0.003	0.997	0.000
M86.93 Osteomyelitis, unspecified (Forearm)	0.000	0.997	0.003
M86.92 Osteomyelitis, unspecified (Upper arm)	0.000	0.997	0.003
M86.91 Osteomyelitis, unspecified (Shoulder region)	0.000	0.997	0.003
M86.90 Osteomyelitis, unspecified (Multiple sites)	0.000	0.997	0.003
M24.26 Disorder of ligament (Lower leg)	0.000	0.997	0.003
C71.0 Cerebrum, except lobes and ventricles	0.003	0.997	0.000
M43.06 Spondylolysis (Lumbar region)	0.003	0.997	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.003	0.997	0.000
M24.89 Other specific joint derangements, not elsewhere classified (Site unspecified)	0.000	0.997	0.003
M24.88 Other specific joint derangements, not elsewhere classified (Other)	0.000	0.997	0.003
M24.80 Other specific joint derangements, not elsewhere classified (Multiple sites)	0.000	0.997	0.003
O86.1 Other infection of genital tract following delivery	0.003	0.997	0.000
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.003	0.997	0.000
B02.9 Zoster without complication	0.000	0.997	0.003
O86.2 Urinary tract infection following delivery	0.003	0.997	0.000
I72 Other aneurysm	0.003	0.997	0.000
M86.95 Osteomyelitis, unspecified (Pelvic region and thigh)	0.000	0.997	0.003
N48.5 Ulcer of penis	0.003	0.997	0.000
Y45.5 4-Aminophenol derivatives	0.003	0.997	0.000
G30 Alzheimer's disease	0.003	0.997	0.000
M24.86 Other specific joint derangements, not elsewhere classified (Lower leg)	0.000	0.997	0.003
N48 Other disorders of penis	0.003	0.997	0.000
M24.85 Other specific joint derangements, not elsewhere classified (Pelvic region and thigh)	0.000	0.997	0.003
N48.9 Disorder of penis, unspecified	0.003	0.997	0.000
Y44.2 Anticoagulants	0.003	0.997	0.000
M86.96 Osteomyelitis, unspecified (Lower leg)	0.000	0.997	0.003
C69.9 Eye, unspecified	0.003	0.997	0.000
I72.1 Aneurysm of artery of upper extremity	0.003	0.997	0.000
C69 Malignant neoplasm of eye and adnexa	0.003	0.997	0.000
M24.83 Other specific joint derangements, not elsewhere classified (Forearm)	0.000	0.997	0.003
M24.82 Other specific joint derangements, not elsewhere classified (Upper arm)	0.000	0.997	0.003
I72.3 Aneurysm of iliac artery	0.003	0.997	0.000
M86.94 Osteomyelitis, unspecified (Hand)	0.000	0.997	0.003
A41.0 Septicaemia due to Staphylococcus aureus	0.000	0.997	0.003
M75.1 Rotator cuff syndrome	0.003	0.997	0.000
M24.41 Recurrent dislocation and subluxation of joint (Shoulder region)	0.000	0.997	0.002
I72.2 Aneurysm of renal artery	0.003	0.997	0.000
B02 Zoster [herpes zoster]	0.000	0.997	0.003
M24.87 Other specific joint derangements, not elsewhere classified (Ankle and foot)	0.000	0.997	0.003
I72.9 Aneurysm of unspecified site	0.003	0.997	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.003	0.997	0.000
M17.0 Primary gonarthrosis, bilateral	0.000	0.997	0.003
O86.8 Other specified puerperal infections	0.003	0.997	0.000
O86.3 Other genito-urinary tract infections following delivery	0.003	0.997	0.000
M86.67 Other chronic osteomyelitis (Ankle and foot)	0.000	0.997	0.003
Y52.4 Angiotensin-converting-enzyme inhibitors	0.003	0.997	0.000
C70 Malignant neoplasm of meninges	0.003	0.997	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.003	0.997	0.000
I72.8 Aneurysm of other specified arteries	0.003	0.997	0.000
C69.6 Orbit	0.002	0.997	0.000
M72.27 Plantar fascial fibromatosis-Ankle/Foot	0.000	0.997	0.003
G30.0 Alzheimer's disease with early onset	0.002	0.997	0.000
N48.8 Other specified disorders of penis	0.002	0.997	0.000
Y52 Agents primarily affecting the cardiovascular system	0.003	0.997	0.000
I72.6 Aneurysm and dissection of vertebral artery	0.002	0.998	0.000
I72.5 Aneurysm and dissection of other precerebral arteries	0.002	0.998	0.000
H10 Conjunctivitis	0.002	0.998	0.000
C69.4 Ciliary body	0.002	0.998	0.000
D05.0 Lobular carcinoma in situ	0.002	0.998	0.000
Y52.1 Calcium-channel blockers	0.002	0.998	0.000
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system	0.002	0.998	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
M86.6 Other chronic osteomyelitis	0.000	0.998	0.002
M24.81 Other specific joint derangements, not elsewhere classified (Shoulder region)	0.000	0.998	0.002
A41.8 Other specified septicaemia	0.000	0.998	0.002
D46.9 Myelodysplastic syndrome, unspecified	0.000	0.998	0.002
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.002	0.998	0.000
M62.89 Other specified disorders of muscle (Site unspecified)	0.000	0.998	0.002
D35.0 Adrenal gland	0.002	0.998	0.000
C69.8 Overlapping lesion of eye and adnexa	0.002	0.998	0.000
C69.5 Lachrymal gland and duct	0.002	0.998	0.000
C69.1 Cornea	0.002	0.998	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.002	0.998	0.000
M86 Osteomyelitis	0.000	0.998	0.002
C70.0 Cerebral meninges	0.002	0.998	0.000
I72.0 Aneurysm of carotid artery	0.002	0.998	0.000
N05.9 Unspecified	0.000	0.998	0.002
Y44 Agents primarily affecting blood constituents	0.002	0.998	0.000
C69.2 Retina	0.002	0.998	0.000
G30.8 Other Alzheimer's disease	0.002	0.998	0.000
K04.9 Other and unspecified diseases of pulp and periapical tissues	0.002	0.998	0.000
S12.20 Fracture of other specified cervical vertebra (closed)	0.000	0.998	0.002
B02.8 Zoster with other complications	0.000	0.998	0.002
B02.7 Disseminated zoster	0.000	0.998	0.002
B02.1 Zoster meningitis	0.000	0.998	0.002
B02.0 Zoster encephalitis	0.000	0.998	0.002
H10.1 Acute atopic conjunctivitis	0.002	0.998	0.000
L40.8 Other psoriasis	0.002	0.998	0.000
N05.1 Focal and segmental glomerular lesions	0.000	0.998	0.002
H10.8 Other conjunctivitis	0.002	0.998	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.998	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.998	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.002	0.998	0.000
Y51.0 Anticholinesterase agents	0.002	0.998	0.000
L40 Psoriasis	0.002	0.998	0.000
C69.0 Conjunctiva	0.002	0.998	0.000
C70.9 Meninges, unspecified	0.002	0.998	0.000
C70.1 Spinal meninges	0.002	0.998	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
I67.9 Cerebrovascular disease, unspecified	0.002	0.998	0.000
Y45.4 Antirheumatics	0.002	0.998	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.002	0.998	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.998	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.002	0.998	0.000
Y52.7 Peripheral vasodilators	0.002	0.998	0.000
M85.89 Other specified disorders of bone density and structure (Site unspecified)	0.000	0.998	0.002
I47.9 Paroxysmal tachycardia, unspecified	0.000	0.998	0.002
L40.3 Pustulosis palmaris et plantaris	0.002	0.998	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.002	0.998	0.000
Y57.9 Drug or medicament, unspecified	0.002	0.998	0.000
Z60.2 Living alone	0.002	0.998	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.002	0.998	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.002	0.998	0.000
Z57.3 Occupational exposure to other air contaminants	0.002	0.998	0.000
H44 Disorders of globe	0.000	0.998	0.002
T51 Toxic effect of alcohol	0.002	0.998	0.000
G30.1 Alzheimer's disease with late onset	0.002	0.998	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.002	0.998	0.000
H10.5 Blepharoconjunctivitis	0.002	0.998	0.000
H10.2 Other acute conjunctivitis	0.002	0.998	0.000
H10.0 Mucopurulent conjunctivitis	0.002	0.998	0.000
Y40.9 Systemic antibiotic, unspecified	0.002	0.998	0.000
N05 Unspecified nephritic syndrome	0.000	0.998	0.002
C72.9 Central nervous system, unspecified	0.002	0.998	0.000
C72.8 Overlapping lesion of brain and other parts of central nervous system	0.002	0.998	0.000
C72.5 Other and unspecified cranial nerves	0.002	0.998	0.000
C72.4 Acoustic nerve	0.002	0.998	0.000
C72.3 Optic nerve	0.002	0.998	0.000
C72.2 Olfactory nerve	0.002	0.998	0.000
C72.1 Cauda equina	0.002	0.998	0.000
D33.3 Cranial nerves	0.000	0.998	0.002
N04.9 Unspecified	0.000	0.998	0.002
O86.4 Pyrexia of unknown origin following delivery	0.002	0.998	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.002	0.998	0.000
M86.68 Other chronic osteomyelitis (Other)	0.000	0.998	0.002
M86.64 Other chronic osteomyelitis (Hand)	0.000	0.998	0.002
M86.63 Other chronic osteomyelitis (Forearm)	0.000	0.998	0.002
M86.62 Other chronic osteomyelitis (Upper arm)	0.000	0.998	0.002
M86.61 Other chronic osteomyelitis (Shoulder region)	0.000	0.998	0.002
M86.60 Other chronic osteomyelitis (Multiple sites)	0.000	0.998	0.002
H10.3 Acute conjunctivitis, unspecified	0.002	0.998	0.000
R79.9 Abnormal finding of blood chemistry, unspecified	0.000	0.998	0.002
M86.69 Other chronic osteomyelitis (Site unspecified)	0.000	0.998	0.002
M86.65 Other chronic osteomyelitis (Pelvic region and thigh)	0.000	0.998	0.002
M90.75 Fracture of bone in neoplastic disease (Pelvic region and thigh)	0.000	0.998	0.002
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.002	0.998	0.000
C72.0 Spinal cord	0.002	0.998	0.000
H02.1 Ectropion of eyelid	0.000	0.998	0.002
N31.8 Other neuromuscular dysfunction of bladder	0.002	0.998	0.000
Y47.1 Benzodiazepines	0.002	0.998	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.002	0.998	0.000
I78.1 Naevus, nonneoplastic	0.002	0.998	0.000
M86.5 Other chronic haematogenous osteomyelitis	0.000	0.998	0.002
M86.4 Chronic osteomyelitis with draining sinus	0.000	0.998	0.002
M86.3 Chronic multifocal osteomyelitis	0.000	0.998	0.002
M86.2 Subacute osteomyelitis	0.000	0.998	0.002
M86.1 Other acute osteomyelitis	0.000	0.998	0.002
M86.0 Acute haematogenous osteomyelitis	0.000	0.998	0.002
Y57 Other and unspecified drugs and medicaments	0.002	0.998	0.000
M11.26 Other chondrocalcinosis (Lower leg)	0.000	0.998	0.002
M86.66 Other chronic osteomyelitis (Lower leg)	0.000	0.998	0.002
N05.7 Diffuse crescentic glomerulonephritis	0.000	0.998	0.002
R82.9 Other and unspecified abnormal finding in urine	0.000	0.998	0.002
Y44.9 Other and unspecified agents affecting blood constituents	0.002	0.998	0.000
Y44.7 Plasma substitutes	0.002	0.998	0.000
Y44.6 Natural blood and blood products	0.002	0.998	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.002	0.998	0.000
K22.4 Dyskinesia of oesophagus	0.002	0.998	0.000
D03.7 Melanoma in situ of lower limb, including hip	0.002	0.998	0.000
K51.5 Mucosal proctocolitis	0.002	0.998	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.002	0.998	0.000
M70.22 Olecranon bursitis-Upper arm	0.000	0.998	0.002
S32.30 Fracture of ilium (closed)	0.002	0.998	0.000
H44.8 Other disorders of globe	0.000	0.998	0.002
L40.4 Guttate psoriasis	0.002	0.998	0.000
L40.2 Acrodermatitis continua	0.002	0.998	0.000
N48.3 Priapism	0.002	0.998	0.000
R93.0 Abnormal findings on diagnostic imaging of skull and head, not elsewhere classified	0.002	0.998	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.002	0.998	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
A40.9 Streptococcal septicaemia, unspecified	0.000	0.998	0.002
H44.4 Hypotony of eye	0.000	0.998	0.002
I45.9 Conduction disorder, unspecified	0.000	0.998	0.002
N05.5 Diffuse mesangiocapillary glomerulonephritis	0.000	0.998	0.002
N48.6 Balanitis xerotica obliterans	0.002	0.998	0.000
O90 Complications of the puerperium, not elsewhere classified	0.002	0.998	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.002	0.998	0.000
M43.0 Spondylolysis	0.002	0.998	0.000
Y44.5 Thrombolytic drugs	0.002	0.998	0.000
Y45.1 Salicylates	0.002	0.998	0.000
O85 Puerperal sepsis	0.002	0.998	0.000
Y58 Bacterial vaccines	0.002	0.998	0.000
C69.3 Choroid	0.002	0.998	0.000
K22.7 Barrett's oesophagus	0.002	0.998	0.000
Y79.2 Prosthetic and other implants, materials and accessory devices	0.000	0.998	0.002
D17.5 Benign lipomatous neoplasm of intra-abdominal organs	0.002	0.998	0.000
H65.4 Other chronic nonsuppurative otitis media	0.000	0.998	0.002
N04.2 Diffuse membranous glomerulonephritis	0.000	0.998	0.002
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.002	0.998	0.000
Y57.6 Other diagnostic agents	0.002	0.998	0.000
N04 Nephrotic syndrome	0.000	0.998	0.002
O85-O92 Complications predominantly related to the puerperium	0.002	0.998	0.000
T51.8 Other alcohols	0.002	0.998	0.000
T51.3 Fusel oil	0.002	0.998	0.000
T51.2 2-Propanol	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations